To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Colorectal cancer; pancreatic cancer
In vitro, cell culture and mouse studies identified a PLK1 inhibitor that could help treat KRAS-driven colorectal and pancreatic
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury